6-31687744-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000395952.8(ABHD16A):c.1448-4C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000395952.8 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD16A | NM_021160.3 | c.1448-4C>G | splice_region_variant, intron_variant | ENST00000395952.8 | NP_066983.1 | |||
ABHD16A | NM_001177515.2 | c.1349-4C>G | splice_region_variant, intron_variant | NP_001170986.1 | ||||
ABHD16A | NR_033488.2 | n.1663-4C>G | splice_region_variant, intron_variant | |||||
ABHD16A | NR_033489.2 | n.1367-4C>G | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD16A | ENST00000395952.8 | c.1448-4C>G | splice_region_variant, intron_variant | 1 | NM_021160.3 | ENSP00000379282.3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246232Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134238
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1460612Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 726618
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74418
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2022 | The c.1448-4C>G intronic alteration consists of a C to G substitution 4 nucleotides before exon 18 of the ABHD16A gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at